Curasight has published the full data from an investigator-initiated phase II trial evaluating its uTRACE imaging technology in brain cancer patients in the peer-reviewed journal EJNMMI Research. The results – which were first reported in connection with an oral presentation at a conference last year – supports the strategy to develop …
